Stay updated on BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL
Sign up to get notified when there's something new on the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page.

Latest updates to the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page
- Check4 days agoChange DetectedVersion bump from v3.0.1 to v3.0.2 with removal of the 'Back to Top' link; no substantive changes to core content, pricing, or scheduling.SummaryDifference0.1%
- Check11 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%
- Check18 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations across various countries, as well as the introduction of new medical terms related to lymphatic diseases. Notably, the previous version's specific drug information and some location terms have been removed.SummaryDifference4%
- Check26 days agoChange DetectedThe page has been updated to reflect an increase in the number of study locations from 67 to 72, with several new investigative sites added in Japan and the Netherlands, while some previous locations in Bavaria have been removed.SummaryDifference2%
- Check33 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check40 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.3%
Stay in the know with updates to BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL
Enter your email address, and we'll notify you when there's something new on the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page.